The researchers discovered that p53-activated NK cells were capable of activating the immune response, transforming melanomas that were unresponsive to anti-PD-1 antibody treatment into tumors that were responsive to anti-PD-1 antibody treatment, thereby altering the immune status from “cold” to “hot” (18). The gene discussed is TP53; the disease is melanoma.